(1)
. . .
.
. ( )
.
.(2)
B A
. 9 5 . .
A
.
(B
)
(A .
.
)
. .( ) 239 230 ) 2002 /
. (1 ) (2 )
2002 28
12
WHO guidelines on the use of vaccines and
http://www.who.int/influenza
antivirals during influenza pandemics. Geneva, World Health Organization, 2004 (WHO/CDS/CSR/RMD/2004, 8; http://www.who.int/csr/resources/publications/influenza WHO_CDS_CSR_RMD_2004_8/en/).
1
90 .( 39 25 .
70 ) 75 39
.
.
: . . 6 . 5 . 23 6 3 4 1 2
.
2003 .2010 75 2006 50
.
.
.
.B A .
2
.
B
A A
10
5 A
. 1918 1957 .
.
.
30
. 20
"
" 40 20 .1968
. 100 000 4 1 000 . 15 5 6 100 000 . 9 5 450 100 000 100
. 100 000 150 30 . 90 . . 6 . 65
.
3
1999 1998 000 2 882 2 785 81 164 2002 . . 15
. . 10 3 ( 3.5) .2002 100 000 100
. 6 . 10 5 . 100 000
(Orthomyxoviridae) C B A A
. . .(" (" ") HA
) .
.NA HA
"
.A .
B
.
( B A NA
. HA
) C B
A
.
.N2
.
. A N1 H3 H2 H1
4
H5N1
. H5N1
. 18 1997 H5N1
. H10N7 H7N3 H7N7 H9N2
.
.
.
.
.
. .
.
. ) M2
A
.
.
( B A
.(
( NA
)
) NA
.(3)
(HA)
.
A
.
. .
.
WHO guidelines on the use of vaccines and antivirals during influenza pandemics. Geneva, World Health Organization, 2004 (WHO/CDS/CSR/RMD/2004, 8; http://www.who.int/csr/resources/publications/influenza WHO_CDS_ CSR_RMD_2004_8/en/).
(3 )
5
.
. A H1N1 H3N2
: .B TIV
(2005)
.(subunit) . . NA HA
:
.
. ( 36 ) 6 9 . . 9 ( ) .
.
.
MF59
.(
) 6
.
. . 90
. . 70
75
39
39
25 .
6
50 . 68 30 . ( 6
(
)
) 60 . . 6 4
.
20 . 6 .
15
.
.
12
) . .
.(
20
.
. 6
. H3N2 H1N1 H2N2
.
B
.
. 3 2003
NA HA
. . .
7
. 49 . . .(CAIV-T) ) 8 7 5
.
.
.( CAIV-T
21 1 . .
.
. 18 .
(4)
.
.
50 .
.
.
Statement on vaccine quality. Global Programme for Vaccines and Immunization policy statement. Geneva, World Health Organization, 1997 (WHO/VSQ/GEN/96.02 Rev.1; http://www.who.int/vaccines-documents/DocsPDF/www9637.pdf).
(4 )
8
: 1 2 ( . . 5 . 23 6 ) 6 3 4
. .
.
.
. .
.
.
9
. 114 . 85
.
.
.
.
.
.
. . 5 . . ■.